Harnessing progress in radiotherapy for global cancer control
- PMID: 37749355
- DOI: 10.1038/s43018-023-00619-7
Harnessing progress in radiotherapy for global cancer control
Abstract
The pace of technological innovation over the past three decades has transformed the field of radiotherapy into one of the most technologically intense disciplines in medicine. However, the global barriers to access this highly effective treatment are complex and extend beyond technological limitations. Here, we review the technological advancement and current status of radiotherapy and discuss the efforts of the global radiation oncology community to formulate a more integrative 'diagonal approach' in which the agendas of science-driven advances in individual outcomes and the sociotechnological task of global cancer control can be aligned to bring the benefit of this proven therapy to patients with cancer everywhere.
© 2023. Springer Nature America, Inc.
Similar articles
-
Technology for Innovation in Radiation Oncology.Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):485-92. doi: 10.1016/j.ijrobp.2015.07.007. Epub 2015 Jul 11. Int J Radiat Oncol Biol Phys. 2015. PMID: 26460989 Free PMC article.
-
Past, present, and future of radiotherapy for the benefit of patients.Nat Rev Clin Oncol. 2013 Jan;10(1):52-60. doi: 10.1038/nrclinonc.2012.203. Epub 2012 Nov 27. Nat Rev Clin Oncol. 2013. PMID: 23183635 Review.
-
Modern radiotherapy for modern surgeons: an update on radiation oncology.ANZ J Surg. 2002 Feb;72(2):131-6. doi: 10.1046/j.1440-1622.2002.02328.x. ANZ J Surg. 2002. PMID: 12074065 Review.
-
Radiation oncology in the era of precision medicine.Nat Rev Cancer. 2016 Apr;16(4):234-49. doi: 10.1038/nrc.2016.18. Epub 2016 Mar 18. Nat Rev Cancer. 2016. PMID: 27009394 Review.
-
50 years of radiotherapy research: Evolution, trends and lessons for the future.Radiother Oncol. 2021 Dec;165:75-86. doi: 10.1016/j.radonc.2021.09.026. Epub 2021 Oct 4. Radiother Oncol. 2021. PMID: 34619236 Review.
Cited by
-
Oral administration of probiotic spore ghosts for efficient attenuation of radiation-induced intestinal injury.J Nanobiotechnology. 2024 May 31;22(1):303. doi: 10.1186/s12951-024-02572-8. J Nanobiotechnology. 2024. PMID: 38822376 Free PMC article.
-
Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance.Cancer Cell. 2025 Jun 9;43(6):1076-1092.e5. doi: 10.1016/j.ccell.2025.03.031. Epub 2025 Apr 10. Cancer Cell. 2025. PMID: 40215978
-
Impact of patient information format on the experience of cancer patients treated with radiotherapy.Tech Innov Patient Support Radiat Oncol. 2024 May 9;30:100252. doi: 10.1016/j.tipsro.2024.100252. eCollection 2024 Jun. Tech Innov Patient Support Radiat Oncol. 2024. PMID: 38779037 Free PMC article. Review.
-
Oversecretion of CCL3 by Irradiation-Induced Senescent Osteocytes Mediates Bone Homeostasis Imbalance.Cells. 2025 Feb 10;14(4):249. doi: 10.3390/cells14040249. Cells. 2025. PMID: 39996722 Free PMC article.
-
Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-c]pyridine Derivatives as Hsp90 Inhibitors.Pharmaceuticals (Basel). 2025 Jan 24;18(2):153. doi: 10.3390/ph18020153. Pharmaceuticals (Basel). 2025. PMID: 40005967 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous